301
Participants
Start Date
February 7, 2006
Primary Completion Date
July 1, 2006
Study Completion Date
July 4, 2006
FF
fluticasone furoate 110 μg nasal spray
Placebo
placebo nasal spray
GSK Investigational Site, Grafton
GSK Investigational Site, Auckland
GSK Investigational Site, Auckland
GSK Investigational Site, Camperdown
GSK Investigational Site, Melbourne
GSK Investigational Site, Parkville
GSK Investigational Site, Clayton
GSK Investigational Site, Kippa-Ring
GSK Investigational Site, Toorak Gardens
GSK Investigational Site, Nedlands
GSK Investigational Site, Berlin
GSK Investigational Site, Tallinn
GSK Investigational Site, Berlin
GSK Investigational Site, Schwerin
GSK Investigational Site, Hamburg
GSK Investigational Site, Wheaton
GSK Investigational Site, Baltimore
GSK Investigational Site, Canton
GSK Investigational Site, Tartu
GSK Investigational Site, Minneapolis
GSK Investigational Site, San Diego
GSK Investigational Site, Moscow
GSK Investigational Site, Moscow
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, North Dartmouth
GSK Investigational Site, Providence
GSK Investigational Site, South Burlington
GSK Investigational Site, Mississauga
GSK Investigational Site, Ottawa
GSK Investigational Site, Toronto
GSK Investigational Site, Trois-Rivières
GSK Investigational Site, Dobele
GSK Investigational Site, Liepāja
GSK Investigational Site, Riga
GSK Investigational Site, Riga
GSK Investigational Site, Tukums
GSK Investigational Site, Kaunas
GSK Investigational Site, Šiauliai
GSK Investigational Site, Vilnius
GSK Investigational Site, Vilnius
GSK Investigational Site, Vilnius
GSK Investigational Site, Moscow
Lead Sponsor
GlaxoSmithKline
INDUSTRY